Obesity Surgery Device Market
Obesity Surgery Device Market Size and Growth
The Obesity Surgery Device market is experiencing significant growth, driven by rising obesity rates and increasing awareness of surgical options. As of 2023, the market size is estimated to exceed $4 billion, with advancements in technology and favorable reimbursement policies further enhancing adoption and driving innovation in surgical solutions. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Johnson & Johnson
◍ Medtronic
◍ Apollo Endosurgery
◍ Medtronic
◍ Mediflex Surgical Product
◍ Aspire Bariatrics
◍ Spatz FGIA
◍ MetaCure
◍ IntraPace
◍ TransEnterix
The obesity surgery device market features key players like Johnson & Johnson, Medtronic, and Apollo Endosurgery, focusing on innovative surgical technologies and minimally invasive solutions. These companies drive market growth through advanced product offerings, strategic partnerships, and expanding healthcare access. Sales revenues include:
- Johnson & Johnson: ~$93.77 billion
- Medtronic: ~$30.12 billion
- Apollo Endosurgery: ~$40 million.
Market Segmentation
By Application
Hospitals
Clinics ◍ Others
By Product
◍ Intragastric Balloons ◍ Gastric Electrical Stimulation ◍ Gastric Bands
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
